v3.25.1
Balance Sheet Components (Tables)
3 Months Ended
Mar. 31, 2025
Balance Sheet Related Disclosures [Abstract]  
Schedule of Inventories
Inventory consisted of the following:
(in thousands)
March 31,
2025
December 31,
2024
Raw materials$15,139 $13,639 
Work-in-process8,905 10,743 
Finished goods5,898 2,126 
Inventory$29,942 $26,508 
Schedule of Property and Equipment, Net
Property and equipment, net consisted of the following:
(in thousands)
March 31,
2025
December 31,
2024
Building and building improvements$109,143 $111,444 
Manufacturing equipment28,537 27,161 
Leasehold improvements25,694 25,673 
Construction in progress
4,866 5,778 
Laboratory equipment3,255 3,183 
Computer equipment and software2,032 2,032 
Furniture and fixtures1,816 1,816 
Total property and equipment175,343 177,087 
Accumulated depreciation(24,273)(21,919)
Property and equipment, net$151,070 $155,168 
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following as of March 31, 2025 and December 31, 2024:
(in thousands)
March 31,
2025
December 31,
2024
Accrued taxes11,429 4,288 
Accrued professional fees4,118 2,659 
Accrued payroll and benefits3,487 9,558 
Other current liabilities3,388 2,403 
Accrued preclinical and clinical expenses2,960 2,537 
Accrued construction in progress
1,346 5,077 
Accrued inventory
1,322 1,217 
Accrued litigation settlement— 31,250 
Accrued expenses and other current liabilities
$28,050 $58,989